These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Abnormalities of molecular biology in premalignant lung lesions]. Shao SJ, Wang Y, Yang PM. Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385 [Abstract] [Full Text] [Related]
4. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Baryshnikova E, Destro A, Infante MV, Cavuto S, Cariboni U, Alloisio M, Ceresoli GL, Lutman R, Brambilla G, Chiesa G, Ravasi G, Roncalli M. Clin Cancer Res; 2008 Mar 15; 14(6):1913-9. PubMed ID: 18347195 [Abstract] [Full Text] [Related]
5. Multi-step evolution of lung cancer. Braithwaite KL, Rabbitts PH. Semin Cancer Biol; 1999 Aug 15; 9(4):255-65. PubMed ID: 10448113 [Abstract] [Full Text] [Related]
6. Tumour biology: senescence in premalignant tumours. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M. Nature; 2005 Aug 04; 436(7051):642. PubMed ID: 16079833 [Abstract] [Full Text] [Related]
7. Genetic diagnosis of pancreatic cancer. Mizumoto K, Tanaka M. J Hepatobiliary Pancreat Surg; 2002 Aug 04; 9(1):39-44. PubMed ID: 12021896 [Abstract] [Full Text] [Related]
8. 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion. TenHave-Opbroek AA, Shi XB, Gumerlock PH. Carcinogenesis; 2000 Aug 04; 21(8):1477-84. PubMed ID: 10910947 [Abstract] [Full Text] [Related]
9. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, Takimoto R, Matsunaga T, Kato J, Sonoda T, Sakamaki S, Niitsu Y. Clin Cancer Res; 2008 Jan 01; 14(1):48-54. PubMed ID: 18172251 [Abstract] [Full Text] [Related]
10. Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers. Capkova L, Kalinova M, Krskova L, Kodetova D, Petrik F, Trefny M, Musil J, Kodet R. Cancer; 2007 Jun 01; 109(11):2299-307. PubMed ID: 17429837 [Abstract] [Full Text] [Related]
11. [New molecular targets in pancreatic cancer]. Torrisani J, Bournet B, Cordelier P, Buscail L. Bull Cancer; 2008 May 01; 95(5):503-12. PubMed ID: 18541514 [Abstract] [Full Text] [Related]
12. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Wang Y, Zhang Z, Lubet RA, You M. Oncogene; 2006 Feb 23; 25(8):1277-80. PubMed ID: 16247444 [Abstract] [Full Text] [Related]
13. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D. Carcinogenesis; 2000 Jul 23; 21(7):1441-51. PubMed ID: 10874024 [Abstract] [Full Text] [Related]
14. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Hoshino H, Shibuya K, Chiyo M, Iyoda A, Yoshida S, Sekine Y, Iizasa T, Saitoh Y, Baba M, Hiroshima K, Ohwada H, Fujisawa T. Lung Cancer; 2004 Nov 23; 46(2):187-96. PubMed ID: 15474667 [Abstract] [Full Text] [Related]
15. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P. Mod Pathol; 2003 Apr 23; 16(4):299-308. PubMed ID: 12692194 [Abstract] [Full Text] [Related]
16. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar 23; 103(3):385-90. PubMed ID: 17321451 [Abstract] [Full Text] [Related]
18. Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk. Jeannon JP, Soames JV, Aston V, Stafford FW, Wilson JA. Clin Otolaryngol Allied Sci; 2004 Dec 23; 29(6):698-704. PubMed ID: 15533163 [Abstract] [Full Text] [Related]
20. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients. Nishisaka T, Takeshima Y, Inai K. Hiroshima J Med Sci; 2000 Jun 23; 49(2):109-16. PubMed ID: 10920577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]